Venturi Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-60
Closed -$4.67K 912
2024
Q4
$4.67K Buy
60
+43
+253% +$3.18K ﹤0.01% 1692
2024
Q3
$1.14K Sell
17
-163
-91% -$13.4K ﹤0.01% 1762
2024
Q2
$20.4K Buy
180
+21
+13% +$2.65K ﹤0.01% 938
2024
Q1
$22.1K Buy
159
+22
+16% +$2.77K ﹤0.01% 714
2023
Q4
$17K Buy
137
+46
+51% +$4.7K ﹤0.01% 745
2023
Q3
$8.49K Buy
91
+48
+112% +$5.41K ﹤0.01% 838
2023
Q2
$5.53K Buy
43
+4
+10% +$484 ﹤0.01% 736
2023
Q1
$4.53K Buy
+39
New +$4.37K ﹤0.01% 847

Other funds holding DXCM

Venturi Wealth Management's DXCM Position: Q1 2025 in Review

Venturi Wealth Management sold out of DexCom (DXCM) in Q1 2025, closing a stake of 60 shares — an estimated $4.67K sold.

Venturi Wealth Management first reported a position in DXCM in Q1 2023 and held it in 8 quarters. The position peaked at $22.1K in Q1 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Venturi Wealth Management reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 60 DexCom shares in Q1 2025, an estimated $4.67K.
  • Venturi Wealth Management first reported a position in DexCom in Q1 2023 and held it in 8 quarters.
  • Venturi Wealth Management's DexCom position peaked at $22.1K in Q1 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.